In the competitive field of Large Peptides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Large Peptides technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Large Peptides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Large Peptides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Large Peptides industry

EP3585402Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell TherapyJUNO THERAPEUTICS, INC.Nov 12, 2024BOULT WADE TENNANT LLP
EP3134120Compositions And Methods For Treating Cytokine-Related DisordersTHE CHILDREN'S HOSPITAL OF PHILADELPHIAOct 23, 2024SANOFI
EP3517134Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses ThereforTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAOct 16, 2024STRAWMAN LIMITED
EP3596123Fc-Optimized Anti-Cd25 For Tumour Specific Cell DepletionCANCER RESEARCH TECHNOLOGY LIMITEDOct 4, 2024PFIZER INC.
EP2849802Treatment Of Amd Using Aav Sflt-1AVALANCHE AUSTRALIA PTY LTD.Sep 19, 2024STRAWMAN LIMITED
EP3823992Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerDUKE UNIVERSITYSep 12, 2024HEMSATH, LARS
EP3480209Expression SystemGLAXOSMITHKLINE BIOLOGICALS S.A.Aug 29, 2024ARGYMA
EP3626737A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant FviiiOCTAPHARMA AGAug 29, 2024AWA SWEDEN AB
EP3626737A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant FviiiOCTAPHARMA AGAug 27, 2024ZWICKER SCHNAPPAUF & PARTNER PATENTANWALTE PARTG MBB
EP3564378Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALS SAJul 25, 2024VALNEVA AUSTRIA GMBH

To stay ahead in the competitive Large Peptides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Large Peptides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2188302Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.11
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX, INC.10
EP3597659Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.9
EP2586788Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.9
EP2261230May 10, 2017Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHA8
EP1974014Apr 19, 2017Oligopeptide-Free Cell Culture MediaBAXTER INTERNATIONAL INC.8
EP2784084Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECH, INC.5
EP3173092Jun 26, 2019Rna Containing Composition For Treatment Of Tumor DiseasesCUREVAC SE5
EP3227454Jan 29, 2020Process For Manipulating The Level Of Glycan Content Of A GlycoproteinAMGEN5
EP3883606Oct 4, 2023Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECH, INC.5